CZAPSKA, Mirella, BABKIEWICZ, Kamila, PABIS, Szczepan and SKÓRZYŃSKA-DZIDUSZKO, Katarzyna. Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus. Journal of Education, Health and Sport. Online. 14 December 2018. Vol. 8, no. 12, pp. 335-351. [Accessed 24 November 2024].